Stem Cell Information Exchange

Wednesday, November 3, 2010

Can Miromatrix “regenerate” Minnesota’s medical industry? An exclusive interview with Dr. Doris Taylor and Miromatrix CEO Rob Cohen « MedCity News

Can Miromatrix “regenerate” Minnesota’s medical industry? An exclusive interview with Dr. Doris Taylor and Miromatrix CEO Rob Cohen « MedCity News
Posted by Vescell at 6:46 AM
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

Followers

Blog Archive

  • ►  2012 (1)
    • ►  March (1)
  • ►  2011 (8)
    • ►  November (1)
    • ►  July (2)
    • ►  June (1)
    • ►  April (1)
    • ►  March (1)
    • ►  February (1)
    • ►  January (1)
  • ▼  2010 (24)
    • ►  December (6)
    • ▼  November (10)
      • California Heart Patient Says Enough is Enough - v...
      • Stem cells in fat may help repair damaged hearts
      • FDA Approves Second Trial of Stem-Cell Therapy - T...
      • Dr. Taylor’s Pioneering Stem Cell Work is Changing...
      • Observations: Expectations for stem cells undergo ...
      • Big Pharma to begin microchipping drugs
      • Can Miromatrix “regenerate” Minnesota’s medical in...
      • U.S. Scientists Use Stem Cells to Produce Human Li...
      • Ipierian Pharmaceuticals Goes After Stem Cell Pate...
      • What are adult stem cells? [Stem Cell Information]
    • ►  October (4)
    • ►  September (4)

About Me

Vescell
I work with a biotechnology company, TheraVitae, that specializes in treating patients with VesCell adult stem cell therapy for heart diseases- such as congestive heart failure, cardiomyopathy, coronary artery disease, and angina. We also treat peripheral artery disease too.
View my complete profile
Ethereal theme. Powered by Blogger.